The utility of a prognostic index for predicting time to first treatment in early chronic lymphocytic leukemia: The GIMEMA experience

Stefano Molica, Francesca R. Mauro, Vincenzo Callea, Diana Giannarelli, Francesco Lauria, Bruno Rotoli, Agostino Cortelezzi, Vincenzo Liso, Robin Foà

Research output: Contribution to journalArticlepeer-review

Abstract

Background: A prognostic index based on widely available clinical and laboratory features was recently proposed to predict survival in patients with previously untreated chronic lymphocytic leukemia. We assessed the utility of this index for predicting time to first treatment in early chronic lymphocytic leukemia. Design and Methods: An observational database of the GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto), which included 310 patients with newly diagnosed Binet stage A chronic lymphocytic leukemia who were observed at different primary hematology centers during the period 1991-2000, was used for the purpose of this study. Results: The new prognostic index enabled Binet stage A patients to be divided into two subgroups that differed with respect to time to first treatment (P=0.003). The original prognostic index was derived from a database that included cases observed at a reference academic center; these patients were younger (P

Original languageEnglish
Pages (from-to)464-469
Number of pages6
JournalHaematologica
Volume95
Issue number3
DOIs
Publication statusPublished - Mar 2010

Keywords

  • Disease progression
  • Early chronic lymphocytic leukemia
  • Prognostic index

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'The utility of a prognostic index for predicting time to first treatment in early chronic lymphocytic leukemia: The GIMEMA experience'. Together they form a unique fingerprint.

Cite this